Clinical trial

Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04431AM2)(COMPLETED)

NCT00381485

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Mometasone furoate/formoterol (MF/F) combination Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Mometasone furoate MDI (MF MDI) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04431AM2)(COMPLETED)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-07-01

PhasePHASE3

Conditions

Asthmaverified · MONDO: asthma

Interventions

Mometasone furoate/formoterol (MF/F) combinationDRUG

Mometasone furoate MDI (MF MDI)DRUG

Sponsors & collaborators

Organon and Colead sponsor

Novartiscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00381485 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.